Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
boston blog main
boston top stories
4
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
boston
fda
new york top stories
san francisco top stories
biotech ipos
national
san diego blog main
acute myeloid leukemia
aligos therapeutics
alx oncology
antibiotics
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
autoimmune diseases
avidity biosciences
baker brothers life sciences
benzodiazepine
berkeley lights
blackstone group
blepharitis
bluebird bio
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
carbapenem-resistant enterobacteriaceae
cavion
What
ipos
4
×
biotechs
ipo
life
medicines
research
science
way
week
ago
arrival
biotech
central
chose
close
cns
companies
company
considering
data
days
device
diseases
disorder
drug
drugs
dyne
early
emerged
expected
experimental
eyes
firms
genetic
hasn’t
having
humans
industry
kept
leads
Language
unset
Current search:
ipos
×
photo
×
" boston top stories "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way